FDA recently issued an emergency use authorization for Merck’s COVID-19 treatment, molnupiravir, for adults 18 years of age and older.
The agency authorized the treatment for adults with high...
Pfizer and BioNTech recently announced that they will amend the clinical study evaluating the safety, tolerability, and immunogenicity of their COVID-19 vaccine in children.
The Phase 1/2/3 trial...
FDA recently approved Pfizer’s Xeljanz (tofacitinib) to treat adults with active ankylosing spondylitis (AS).
The agency approved the drug specifically for individuals who have had an inadequate...
The Strategic Advisory Group of Experts on Immunization (SAGE) for the World Health Organization (WHO) recently supported using Johnson & Johnson’s COVID-19 vaccine booster shot in...
GSK recently welcomed the decision of the Gavi Board to fund the procurement and introduction of malaria vaccines into routine child immunization programs in eligible countries.
GSK developed its...
FDA recently approved imaging drug Cytalux to assist surgeons in identifying ovarian cancer lesions.
Cytalux is approved for use in adult patients with ovarian cancer to help identify...
Johnson & Johnson recently announced a potential licensing agreement for its COVID-19 vaccine with Aspen SA Operations (Pty) Ltd, based in South Africa.
The companies will work towards a...
Specialty drugs accounted for 51.4 percent of the net cost in Medicaid and 1.3 percent of utilization in 2020, according to a Magellan Health trend report.
The Medicaid Pharmacy Trend Report looked at...
GSK recently appointed Phil Dormitzer, MD, PhD, as global head of vaccines research and development and a member of the vaccines leadership team.
Previously, Dormitzer was vice president and chief...
A federal jury recently held CVS, Walgreens, and Walmart pharmacies accountable for their role in an opioid crisis in two Ohio counties, according to a report from the Associated Press.
Between 2012...
FDA recently granted breakthrough device designation for Datar Cancer Genetics’ blood test to detect early-stage breast cancer.
The test, TriNetra, uses proprietary technology to detect...
FDA recently approved PharmaEssentia’s injection to treat adults with polycythemia vera, a rare blood disease that causes overproduction of red blood cells.
The monopegylated, long-acting...
Abbott recently released research from its multi-year global research program, which found that advancing diagnostic testing for vascular diseases can help hospitals and physicians improve the patient...
Abbott and the American Diabetes Association (ADA) recently launched a joint community health partnership to address diabetes care management among people of color (POC) living with the...
The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recently recommended the approval of Roche’s COVID-19 antibody combination, Ronapreve.
CHMP...
FDA recently approved Novartis’ Scemblix to treat chronic myeloid leukemia (CML) for adult and pediatric patients with Philadelphia chromosome-positive CML in chronic phase.
Scemblix is the...
The US government recently purchased additional doses of Eli Lilly and Company’s combination COVID-19 antibody treatment.
Under the agreement, Eli Lilly and Company will supply 614,000 doses of...
FDA recently granted emergency use authorization to Thermo Fisher Scientific to run new saliva sample collection methods on its COVID-19 tests.
The company’s molecular diagnostics Spectrum...
FDA recently accepted Novartis’ biologics license application for Beovu, the company’s diabetic macular edema (DME) drug.
Specifically, FDA accepted the application for six...
FDA recently approved a new low-dose tablet dosage form of Gilead’s HIV-1 drug, Biktarvy, in pediatric patients.
The agency approved the new dosage for children weighing at least 30 pounds who...
